United States · FDA National Drug Code directory
Adalimumab-bwwd
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 83457-186_e4f35584-c5c1-4878-a715-8e09c488d05e
- Product NDC
- 83457-186
- Form
- SOLUTION
- Composition / generic term
- adalimumab-bwwd
- Labeler
- Cordavis Limited
- Marketing category
- BLA
- Marketing start / end (source format)
- 20251212
- Source listing expiry
- 20271231
Source-listed ingredients
- ADALIMUMAB — 40 mg/.4mL
These values do not establish equivalence or a dose recommendation.
Packages
- 2 SYRINGE in 1 CARTON (83457-186-01) / .4 mL in 1 SYRINGE (83457-186-99) · 83457-186-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →